Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
A Practical Approach to Vasculitis
Description
The presentation on vasculitis outlines a practical, evidence-based approach to understanding and managing this complex condition, particularly its cutaneous manifestations. It defines vasculitis as inflammation of blood vessels, which can lead to tissue damage, and emphasizes the importance of correlating clinical observations with pathology findings. The discussion explains how to classify vasculitis based on the affected vessel sizes—small, medium, or large—and illustrates this with case examples. The speaker emphasizes that valid diagnoses rely on detailed observations of skin lesions and potentially involve biopsies to confirm findings. The importance of differential diagnoses is addressed, noting that similar presentations can arise from non-vasculitic conditions. The significance of laboratory tests, especially urinalysis, is highlighted in monitoring potential systemic involvement in vasculitis patients. The talk also cautioned against over-testing while underscoring the necessity of a thorough review of systems. The skin lesions not only indicate a possible diagnosis but also serve as prognostic markers for underlying or systemic conditions. Overall, the session promotes a methodical approach to evaluating vasculitis in dermatological practice, balancing the need for thorough investigation with the practicalities of clinical assessment.
View moreConclusions
- Vasculitis is defined as inflammation and destruction of blood vessels, leading to tissue damage.
- The classification of vasculitis is based on the size of the affected blood vessels and can correlate with specific clinical manifestations.
- Skin findings in vasculitis can provide insights into the diagnosis and potential systemic involvement.
- Patients with cutaneous manifestations of ANCA-associated vasculitis are more likely to present with severe systemic issues, such as glomerulonephritis and alveolar hemorrhage.
- When diagnosing vasculitis, a biopsy showing leukocytoclasis and fibrinoid necrosis is critical for confirmation.
- Initial work-up for suspected vasculitis should include evaluation of systemic involvement and whether the lesions in question are indeed due to vasculitis.
- The urinalysis is vital in assessing for renal involvement, particularly in cases of IgA vasculitis.
- Subcutaneous nodules and significant ulcerations typically suggest medium vessel vasculitis rather than small vessel involvement.
- Treatment decisions are influenced by whether there is systemic involvement; skin-limited vasculitis should be managed conservatively when systemic disease is excluded.
- Clinical-pathologic correlation is essential to avoid misdiagnosis of vasculitis, as several conditions can mimic its clinical presentation.
- Ongoing research aims to establish an evidence-based approach and optimize treatment protocols for skin-limited vasculitis.
- Diagnostic and Classification Criteria in Vasculitis Study (DCVAS) Arthritis Rheumatol. 2020. Oct;72(10):1741-1747.
- Arch Dermatol 2006;142:155-61. Br J Dermatol 2014;171(6):1397-401.
- J Am Acad Dermatol 2010;63(6):1026-9.
- J Am Acad Dermatol. 2023 Sep;89(3):582-584.
- Clin Pediatr 2007;46:451.
- J Am Acad Dermatol 1994;30(5 Pt 2):854-5.
- Clin Dermatol 2006;24(5):414-29.
- Curr Rheumatol Rep 2014;16(9):440.
- Medicine 2013;92(6):331-43.
- Rheum Dis Clin North Am. 2015;41(1):21-32, vii.
- Am J Clin Dermatol. 2023 Jan;24(1):89-95.
- JAMA Dermatol. 2023 Jun 1;159(6):667-669.